Committed to Improving the Lives of Patients Worldwide
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer.
As committed as we are to clinical accomplishment, we are equally committed to
Explore Celgene's history - from our modest beginnings to our current position as a globally integrated and culturally diverse biopharmaceutical company.
Celgene employs more than 4,500 employees worldwide. Learn about the values that define our people.
Our commitment to patients extends around the world. Find a comprehensive listing of domestic and international Celgene offices.
Discover Celgene's deep and diverse intellectual property portfolio - a variety of novel scientific targets and approaches.